DGEFX
Price
$14.56
Change
+$0.34 (+2.39%)
Updated
Feb 3 closing price
Net Assets
501.71M
EPSYX
Price
$26.10
Change
+$0.53 (+2.07%)
Updated
Feb 3 closing price
Net Assets
887.77M
Interact to see
Advertisement

DGEFX vs EPSYX

Header iconDGEFX vs EPSYX Comparison
Open Charts DGEFX vs EPSYXBanner chart's image
Destinations Equity Income I
Price$14.56
Change+$0.34 (+2.39%)
VolumeN/A
Net Assets501.71M
NYLI Epoch Global Equity Yield
Price$26.10
Change+$0.53 (+2.07%)
VolumeN/A
Net Assets887.77M
DGEFX vs EPSYX Comparison Chart in %
View a ticker or compare two or three
VS
DGEFX vs. EPSYX commentary
Feb 05, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is DGEFX is a Buy and EPSYX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
EPSYX has more cash in the bank: 888M vs. DGEFX (502M). EPSYX pays higher dividends than DGEFX: EPSYX (2.18) vs DGEFX (1.83). DGEFX was incepted earlier than EPSYX: DGEFX (9 years) vs EPSYX (20 years). DGEFX (1.07) is less costly to investors than EPSYX (0.89). DGEFX is a more actively managed with annual turnover of: 45.00 vs. EPSYX (30.00). DGEFX has a lower initial minimum investment than EPSYX: DGEFX (0) vs EPSYX (1000000). EPSYX annual gain was more profitable for investors over the last year : 17.89 vs. DGEFX (15.03). DGEFX (63.46) and EPSYX (61.23) have equivalent 5 years return.
DGEFXEPSYXDGEFX / EPSYX
Total Expense Ratio0.940.84112%
Annual Report Gross Expense Ratio1.070.89120%
Fund Existence9 years20 years-
Gain YTD6.2005.668109%
Front LoadN/AN/A-
Min. Initial Investment01000000-
Min. Initial Investment IRAN/AN/A-
Net Assets502M888M57%
Annual Yield % from dividends1.832.1884%
Returns for 1 year15.0317.8984%
Returns for 3 years36.7641.0090%
Returns for 5 years63.4661.23104%
Returns for 10 yearsN/A85.80-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
LCTX1.760.22
+14.29%
Lineage Cell Therapeutics
IMAX35.640.51
+1.45%
Imax Corp
DDT26.20-0.01
-0.04%
Dillard's Capital Trust I
SARO30.53-0.41
-1.33%
StandardAero Inc
BDL31.34-0.46
-1.45%
Flanigan's Enterprises